May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Carbonic Anhydrase I (CA–1) Induces Retinal Vascular Permeability in vivo through the Bradykinin (BK)/Kallikrein Pathway
Author Affiliations & Notes
  • A.C. Clermont
    Beetham Eye Institute, Joslin Diabetes Center/Harvard Medical School, Boston, MA
  • S. Rook
    Beetham Eye Institute, Joslin Diabetes Center/Harvard Medical School, Boston, MA
  • B. Gao
    Beetham Eye Institute, Joslin Diabetes Center/Harvard Medical School, Boston, MA
  • S.E. Bursell
    Beetham Eye Institute, Joslin Diabetes Center/Harvard Medical School, Boston, MA
  • L.P. Aiello
    Beetham Eye Institute, Joslin Diabetes Center/Harvard Medical School, Boston, MA
  • E.P. Feener
    Beetham Eye Institute, Joslin Diabetes Center/Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships  A.C. Clermont, None; S. Rook, None; B. Gao, None; S.E. Bursell, None; L.P. Aiello, None; E.P. Feener, None.
  • Footnotes
    Support  Massachusetts Lions
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5183. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.C. Clermont, S. Rook, B. Gao, S.E. Bursell, L.P. Aiello, E.P. Feener; Carbonic Anhydrase I (CA–1) Induces Retinal Vascular Permeability in vivo through the Bradykinin (BK)/Kallikrein Pathway . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5183.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Extracellular CA and bicarbonate levels regulate transcellular ion and water transport. While CA plays a role in ocular fluid homeostasis, its effect on retinal vascular permeability (RVP) has not been described. This study investigates whether extracellular CA has an effect upon retinal vascular permeability. Methods: RVP was measured by vitreous fluorophotometry in male Sprague–Dawley rats. After baseline measurements, 10 µL intravitreal injections of CA (Sigma) or balanced salt solution (BSS) were performed. Fluorescein was infused into a jugular catheter 15 minutes after injection. Vitreal fluorescence was measured 30 minutes later. Fluorescent spectra were normalized by the incident light intensity. Results: CA increased RVP in a dose dependent manner, with a maximal increase of 120% (20.7+4.4au, p<0.05) at 2ng/µL compared with BSS control (9.8+3.4au). The EC50 of CA–1 was 670 pg/µL and the CA–mediated increase in RVP was sustained for over 24 hrs. The effect of CA–1 alone on RVP was comparable in magnitude to the effect of intravitreal injected VEGF and the two responses were additive. CA–1–induced BRB permeability was inhibited by 68% with co–injection of 10um acetazolamide (13.3±5.1au, p<0.05), 75% with 150 uM of the BK receptor 2 anatgonist HOE–140 (11.1±2.4au, p<0.05), and 70% with 100µM of the carboxypeptidase inhibitor, leupeptin (10.8±2.5au, p< 0.05). Conclusions: CA is a potent retinal permeability factor that exerts its effect through the bradykinin pathway independently of VEGF. The results suggest that CA could be a physiological activator of the kallikrein–kinin system.

Keywords: signal transduction: pharmacology/physiology • vascular cells • enzymes/enzyme inhibitors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×